IDLDX.ST STO
IDL Diagnostics AB (publ)
1W: -4.6%
1M: -8.0%
3M: -7.5%
YTD: +5.1%
1Y: -21.3%
kr 0.37 ($0.04)
+0.00 (+0.00%)
Weekly Expected Move ±6.6%
kr 0
kr 0
kr 0
kr 0
kr 0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$53M
-7.5% ▼
5Y CAGR: +263.2%
Gross Profit
$28M
+136.2% ▲
5Y CAGR: +237.8%
Operating Income
-$12M
+72.4% ▲
Net Income
-$12M
+71.4% ▲
EPS (Diluted)
$-0.05
+70.7% ▲
EBITDA
-$12M
+65.1% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $12M | $37M | $43M | $57M | $53M |
| YoY Growth | +14181.0% | +208.3% | +16.4% | +33.5% | -7.5% |
| Cost of Revenue | $17M | $39M | $45M | $46M | $25M |
| Gross Profit | -$5M | -$2M | -$2M | $12M | $28M |
| Gross Margin | -42.1% | -5.7% | -4.9% | 20.4% | 52.2% |
| R&D Expenses | $20M | $24M | $25M | $23M | $0 |
| SG&A Expenses | $26M | $36M | $33M | $34M | $25M |
| Operating Expenses | $46M | $58M | $58M | $55M | $40M |
| Operating Income | -$51M | -$59M | -$60M | -$43M | -$12M |
| Operating Margin | -421.6% | -160.3% | -138.9% | -75.6% | -22.6% |
| Interest Expense | $1K | $5K | $13K | $3K | $445K |
| Income Before Tax | -$51M | -$59M | -$59M | -$42M | -$12M |
| Tax Expense | $0 | -$326K | $0 | $0 | $0 |
| Net Income | -$50M | -$59M | -$59M | -$42M | -$12M |
| Net Margin | -417.0% | -159.4% | -137.8% | -73.9% | -22.9% |
| EPS (Diluted) | $-0.52 | $-0.27 | $-0.26 | $-0.18 | $-0.05 |
| EBITDA | -$30M | -$12M | -$14M | -$34M | -$12M |
| Shares Outstanding | 96M | 215M | 230M | 230M | 230M |